Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / ADR
-
Shares outstanding
-
55,574,229
-
Total 13F shares
-
58,376,386
-
Share change
-
-125,429
-
Total reported value
-
$7,851,336,290
-
Put/Call ratio
-
126%
-
Price per share
-
$134.53
-
Number of holders
-
168
-
Value change
-
-$60,447,865
-
Number of buys
-
88
-
Number of sells
-
74
Institutional Holders of Ascendis Pharma A/S - ADR (ASND) as of Q4 2021
As of 31 Dec 2021,
Ascendis Pharma A/S - ADR (ASND) was held by
168 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
58,376,386 shares.
The largest 10 holders included
Artisan Partners Limited Partnership, RA CAPITAL MANAGEMENT, L.P., FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, BAKER BROS. ADVISORS LP, WELLINGTON MANAGEMENT GROUP LLP, JANUS HENDERSON GROUP PLC, WESTFIELD CAPITAL MANAGEMENT CO LP, Avoro Capital Advisors LLC, and EVENTIDE ASSET MANAGEMENT, LLC.
This page lists
168
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.